Caris Life Sciences Publishes Study Highlighting the Value of Comprehensive Molecular Profiling in Characterizing ESR1-Mutated Metastatic Breast Cancer
Caris Life Sciences published a study in Clinical Cancer Research demonstrating that comprehensive molecular profiling provides crucial insights beyond simple ESR1 mutation status in metastatic breast cancer. Findings suggest ESR1 variant type,